Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.
Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J, Bacigalupo A, Beelen D, Reiffers J, Devergie A, Alessandrino E, Mufti GJ, Barge R, Sierra J, Ruutu T, Boogaerts M, Falda M, Jouet JP, Niederwieser D, de Witte T; Myelodysplastic Syndrome subcommittee of the Chronic Leukemia Working Party of the European Blood and Marrow Transplantation Group. Martino R, et al. Among authors: ruutu t. Blood. 2006 Aug 1;108(3):836-46. doi: 10.1182/blood-2005-11-4503. Epub 2006 Apr 4. Blood. 2006. PMID: 16597592 Free article.
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Ringdén O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Ljungman P, et al. Ringdén O, et al. Among authors: ruutu t. Blood. 1994 May 1;83(9):2723-30. Blood. 1994. PMID: 8167351 Free article. Clinical Trial.
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A, Hermans J, van Biezen A, Arcese W, Debusscher L, Ernst P, Ferrant A, Frassoni F, Gahrton G, Iriondo A, Kolb HJ, Link H, Niederwieser D, Ruutu T, Siegert W, Zwaan FE. Gratwohl A, et al. Among authors: ruutu t. Br J Haematol. 1996 Dec;95(3):494-500. doi: 10.1046/j.1365-2141.1996.d01-1929.x. Br J Haematol. 1996. PMID: 8943890 Clinical Trial.
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A. van Rhee F, et al. Among authors: ruutu t. Bone Marrow Transplant. 1997 Oct;20(7):553-60. doi: 10.1038/sj.bmt.1700933. Bone Marrow Transplant. 1997. PMID: 9337056 Free article.
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A, Frassoni F, Gahrton G, Kolb HJ, Niederwieser D, Ruutu T, Vernant JP, de Witte T, Apperley J. Gratwohl A, et al. Among authors: ruutu t. Lancet. 1998 Oct 3;352(9134):1087-92. doi: 10.1016/s0140-6736(98)03030-x. Lancet. 1998. PMID: 9798583
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.
Carreras E, Bertz H, Arcese W, Vernant JP, Tomás JF, Hagglund H, Bandini G, Esperou H, Russell J, de la Rubia J, Di Girolamo G, Demuynck H, Hartmann O, Clausen J, Ruutu T, Leblond V, Iriondo A, Bosi A, Ben-Bassat I, Koza V, Gratwohl A, Apperley JF. Carreras E, et al. Among authors: ruutu t. Blood. 1998 Nov 15;92(10):3599-604. Blood. 1998. PMID: 9808553 Free article.
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Ringdén O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Mellander L, Ljungman P, Jacobsen N. Ringdén O, et al. Among authors: ruutu t. Blood. 1999 Apr 1;93(7):2196-201. Blood. 1999. PMID: 10090927 Free article. Clinical Trial.
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.
Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A, Bunjes D, Gluckman E, Ruutu T, Schaefer UW, Sierra J, Vernant JP, Willemze R, de Witte T, Gorin NC. Frassoni F, et al. Among authors: ruutu t. Lancet. 2000 Apr 22;355(9213):1393-8. doi: 10.1016/s0140-6736(00)02137-1. Lancet. 2000. PMID: 10791522
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
de Witte T, Hermans J, Vossen J, Bacigalupo A, Meloni G, Jacobsen N, Ruutu T, Ljungman P, Gratwohl A, Runde V, Niederwieser D, van Biezen A, Devergie A, Cornelissen J, Jouet JP, Arnold R, Apperley J. de Witte T, et al. Among authors: ruutu t. Br J Haematol. 2000 Sep;110(3):620-30. doi: 10.1046/j.1365-2141.2000.02200.x. Br J Haematol. 2000. PMID: 10997974 Free article.
299 results